Autoantibody of NRIP, a novel AChR‐interacting protein, plays a detrimental role in myasthenia gravis

• Үндсэн зохиолчид: Li‐Kai Tsai (Зохиогч), I‐Hsin Chen (Зохиогч), Chi‐Chao Chao (Зохиогч), Hsueh‐Wen Hsueh (Зохиогч), Hsin‐Hsiung Chen (Зохиогч), Yun‐Hsin Huang (Зохиогч), Rong‐Wei Weng (Зохиогч), Tzu‐Yun Lai (Зохиогч), Yi‐Chieh Tsai (Зохиогч), Yeou‐Ping Tsao (Зохиогч), Show‐Li Chen (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Wiley, 2021-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Background Nuclear receptor interaction protein (NRIP) co‐localizes with acetylcholine receptor (AChR) at the neuromuscular junction (NMJ), and NRIP deficiency causes aberrant NMJ architecture. However, the normal physiological and pathophysiological roles of NRIP in NMJ are still unclear....